文 献6）Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48(3): 452-8.7）Scalera S, Mazzotta M, Corleone G, Sperati F, Terrenato I, Krasniqi E, et al. KEAP1 and TP53 frame genomic, evolutionary, and immunologic subtypes of lung adenocarcinoma with different sensitivity to immunotherapy. J Thorac Oncol 2021; 16(12): 2065-77.8）Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, Boxtel RV, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 2015; 521(7550): 43-7.9）Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 2018; 362(6411): eaar3593.10）Jung J, Heo YJ, Park S. High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. J Immunother Cancer 2023; 11(4): e006454.1001）Grant MJ, Herbst RS, Goldberg SB. Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC. Nat Rev Clin Oncol 2021; 18(10): 625-44.2）Singh N, Temin S, Baker Jr S, Blanchard E, Brahmer JR, Celano P, et al. Therapy for stage IV non-small-cell lung cancer without driver alterations: ASCO living guideline. J Clin Oncol 2022; 40(28): 3323-43.3）Li A, Wang Y, Yu Z, Tan Z, He L, Fu S, et al. STK11/LKB1-deficient phenotype rather than mutation diminishes immunotherapy efficacy and represents STING/type I interferon/CD8＋ T-cell dysfunction in NSCLC. J Thorac Oncol 2023; 18(2): 1714-30.4）Ravi A, Hellmann MD, Arniella MB, Holton M, Freeman SS, Naranbhai V, et al. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. Nat Genet 2023; 55(5): 807-19.5）Pestinger V, Smith M, Sillo T, Findlay JM, Laes JF, Martin G, et al. Use of an integrated pan-cancer oncology enrichment next-generation sequencing assay to measure tumour mutational burden and detect clinically actionable variants. Mol Diagn Ther 2020; 24(3): 339-49.
元のページ ../index.html#114